A treatment of colorectal cancer cells (HT-29) with Se-allylselenocysteine (ASC) has been shown to induce a demethylation of the PCDH17 promoter associated with an increase in PCDH17 expression and an activation of autophagy [24]. This evidence concerns the gene PCDH17 and colorectal cancer.